Product ID: SQSG35H2017
Report ID: SQSG35H2017 | Region: Global | Published Date: October, 2022 | Pages: 285 | Tables: 117 | Figures: 78
Global T-cell Therapy Market size was valued at USD 7095.83 million in 2021 and is poised to grow from USD 8344.7 million in 2022 to USD 35898.15 million by 2030, growing at a CAGR of 17.6% in the forecast period (2023-2030).
One of the main causes of mortality across the globe is cancer. It is predicted that by the end of 2040, there will be an additional 27.5 million cancer cases worldwide, placing a significant financial, emotional, and physical burden on those who are affected, their families, communities, and national health systems. Although there are several treatments available to slow the disease's growth and prevent cancer cells from spreading throughout the body, achieving a long-lasting remission is challenging.
In this regard, immunotherapies, a more recent addition to the spectrum of anticancer treatments, have shown a lot of promise. T-cell therapies (more specifically, CAR-T therapies, TCR therapies, and TIL therapies) have emerged as a promising option among the current efforts made to develop more targeted anti-cancer therapies. This is due to their capacity to eradicate tumor cells from the body with a minimum of treatment-related side effects. Globally, cancer treatment has been transformed by this very effective and promising type of T-cell therapy, which uses the adaptable effector apparatus of the human immune system. This emerging therapeutic area is on its way to become one of the highest valuable markets within the biopharmaceutical sector, given the steadily rising number of cell treatments being developed and introduced.
US T-cell Therapy Market is poised to grow at a sustainable CAGR for the next forecast year.
To get more reports on the above market click here to Buy The Report
Global T cell therapy Market is segmented based on the modality, type, indication, end user, and region. Based on modality, the T cell therapy market is bifurcated into research and commercialized. According to type the market is sub‑segmented into CAR T-cell Therapy, T Cell Receptor (TCR)-based and Tumor Infiltrating Lymphocytes (TIL)-based. On the basis of indication, it is categorized into Hematologic Malignancies, Solid Tumors and others. By end user, the market is segmented into hospitals, specialty clinics, homecare, others. Based on region, it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.
T-cell Therapy Market Analysis by Modality
The research segment accounted for the highest market share during 2021 and accounted for approximately 76% of revenue share of global revenue in 2021. This can be attributed to the high number of products in the clinical development phase. Many research institutions, like Mayo Clinic, are actively involved in running CAR-T treatment programmes, promoting the approach as a better way to control cancer. The shift in emphasis on accelerate the development of CAR-T treatments to broaden the therapeutic application landscape is the product of many operating companies working with research groups throughout the world.
Regulating organisations, on the other hand, are working hard to promote the commercial use of these treatments in clinical and hospital settings. The Centers for Medicare and Medicaid Services (CMS) has unveiled standards regarding CAR-T cell treatment payment and coverage. Due to this policy, the money received climbed to 65% of the entire cost. This would encourage a rise in commercial income.
T-cell Therapy Market Analysis by Type
The segment of CAR T-cell held the largest market share in 2021 and accounted for approximately 83% of revenue share of global revenue. This is because there are now an increasing number of clinical studies for CAR-T therapy, and important actors in this field are becoming more involved. Clinical studies for CAR-T therapy items are being conducted by a sizable number of new players and academic institutions for both the same and different indications, strengthening the segment's dominance. The use of CAR-T treatments in the treatment of different tumours has increased as a result of improvements in CAR-T therapy production. By overcoming obstacles like resistance and side effects, emerging strategies like second- and next-generation CAR-T immunotherapy may increase the creation of organic income.
In addition, T-cell receptor-based treatments, which have the potential to treat solid tumours, are ranked second globally. For the treatment of melanoma, this area is attracting a lot of interest.
To get detailed analysis on other segments, Request For Sample Report
North America held the largest market share of Global T cell therapy Market in 2021 and accounted for the largest revenue share of around 41% in 2021. Strong research, a thriving industry, and a significant number of clinical trials for T-cell treatments being carried out in the U.S. have all significantly aided in the region's market supremacy. Additionally, the market has grown significantly as a result of the rising number of regulatory approvals in the U.S. and Canada as well as the region's shifting reimbursement environment. Additionally, the expansion of the regional market is aided by the large number of medical facilities that provide CAR-T cell therapy.
Asia Pacific region is expected to witness the fastest growth rate during the forecast period with growing markets like China leading the way. China now boasts the most registered clinical trials for CAR-T therapies, making it a viable market for these treatments in recent years. Focused efforts on government spending and reforms in the region have ultimately led to tremendous development of the market.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
T-cell Therapy Market Driver
T-cell Therapy Market Restraint
Speak to one of our ABIRAW analyst for your custom requirements before the purchase of this report
Global T cell therapy Market is fragmented and competitive due to the presence of major players. Companies are clamouring to invest in the creation of innovative CAR T-cell treatment due to the exponential increase in the use of precision medicine on a worldwide scale. To maintain a competitive edge and increase their market position in the worldwide Tcell therapy market, leading companies are increasingly focusing on implementing tactics such as adopting new technology, product developments, mergers and acquisitions, joint venture, alliances, and partnerships. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.
T-cell Therapy Market Top Player's Company Profiles
T-cell Therapy Market Recent Developments
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.
According to our Global T cell therapy Market analysis, the need for CAR T-cell treatment is anticipated to develop dramatically as a result of the growing elderly population and the rise in lymphoma and leukaemia cases worldwide. During the projection period for the global T-cell therapy market, it is expected to create lucrative prospects for growth due to the rise in awareness and rise in approval of novel CAR T-cell therapy treatments and promising medications currently in development. Furthermore, a growth in the demand for the best therapies for treating cancer, a rise in the incidence of the disease, advantageous payment policies for CAR T-cell therapy drugs in some countries, and an increase in public knowledge of these drugs. The market for T-cell treatment is rising due to the recent commercialization of CAR-T cell therapy and the fast growing clinical trial activities, both of which are anticipated to present profitable potential for market growth.
|Market size value in 2021||USD 7095.83 million|
|Market size value in 2030||USD 8344.7 million|
|Forecast Unit (Value)||USD Million|
|Regions covered||North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)|
Free report customization with purchase. Customization includes:-
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Parent Market Analysis
KEY MARKET INSIGHTS
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Global T-cell Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global T-cell Therapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global T-cell Therapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global T-cell Therapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "
- Mr. Ali Zali, Commercial Director, ICIIC Iran.